- Article
Metformin as an Enhancer for the Treatment of Chemoresistant CD34+ Acute Myeloid Leukemia Cells
- Indre Krastinaite,
- Sergej Charkavliuk,
- Ruta Navakauskiene and
- Veronika Viktorija Borutinskaite
Acute myeloid leukemia is the second most frequent type of leukemia in adults. Due to a high risk of development of chemoresistance to first-line chemotherapy, the survival rate of patients in a 5-year period is below 30%. One of the reasons is that...

